Time for a pitstop to reflect on some ASCO24 data

Day 1 at ASCO is usual a nice easy glide into the clinical sessions with barely a moment of controversy to be seen.

Not this year, however.

If you’re going to buck the trend then you might as well do it with a splash – something which can be interpreted positively or negatively depending upon your perspective.

Talking of pitstops always reminds me of those colourful Hanna-Barbera Wacky Races cartoons so familiar from our childhood with their insanely odd vehicles and absurd plot developments.

Are some of the claims coming out of Chicago living up to these expectations one might well wonder?

In the first of our daily commentaries from the annual meeting, we take a look at four very different trial readouts and discuss the issues they raise because all is not what it seems in some cases…

To learn more from our latest oncology review and get a heads up on key cancer research insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by